Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN

RogerK. Ferguson, Hans-R. Brunner, GustaveA. Turini et al. · The Lancet · 1977 · 325 citations

Hypertension, Medicinal Chemistry, Medicine +9

Enalapril maleate and a lysine analogue (MK‐521): disposition in man.

E H Ulm, M Hichens, HJ Gomez et al. · British Journal of Clinical Pharmacology · 1982 · 213 citations · Full text

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

Jérôme Biollaz, Michel Burnier, G. A. Turini et al. · Clinical Pharmacology & Therapeutics · 1981 · 147 citations

Hypertension, Heart Failure, Cardiovascular Pharmacology +16

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

D. B. Brunner, G Desponds, Jérôme Biollaz et al. · British Journal of Clinical Pharmacology · 1981 · 127 citations · Full text

Hypertension, Healthy Subjects, Cardiovascular Pharmacology +20

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

D. B. Brunner, G Desponds, Jérôme Biollaz et al. · British Journal of Clinical Pharmacology · 2004 · 117 citations · Full text

Molecular Pharmacology, Hypertension, Lysine Analogue +15